These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 622534

  • 1. [Influenza vaccination in dialysis patients].
    Haldimann B, Descoeudres C.
    Schweiz Med Wochenschr; 1978 Jan 14; 108(2):52-5. PubMed ID: 622534
    [Abstract] [Full Text] [Related]

  • 2. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
    Trmal J, Havlícková M, Bícová R, Bitterová Z, Kelerová J.
    Epidemiol Mikrobiol Imunol; 2005 Aug 14; 54(3):123-8. PubMed ID: 16173523
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T.
    Scand J Urol Nephrol; 2003 Aug 14; 37(1):71-6. PubMed ID: 12745749
    [Abstract] [Full Text] [Related]

  • 5. [Staff vaccination with a new subunit influenza vaccine].
    Just M, Moritz A, Schoch J, Lattmann P.
    Schweiz Med Wochenschr; 1978 Jan 14; 108(2):47-52. PubMed ID: 622533
    [No Abstract] [Full Text] [Related]

  • 6. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N, Engelmann H, Künzel W, Neumeier E, Sänger R.
    Med Microbiol Immunol; 2002 Dec 14; 191(3-4):203-8. PubMed ID: 12458361
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults.
    Ben-Yehuda A, Joseph A, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Barenholz Y, Kedar E.
    J Med Virol; 2003 Apr 14; 69(4):560-7. PubMed ID: 12601765
    [Abstract] [Full Text] [Related]

  • 8. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR, Rizzone C, DeMello S, Ogra PL.
    Dev Biol Stand; 1976 Aug 27; 33():162-70. PubMed ID: 782964
    [Abstract] [Full Text] [Related]

  • 10. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD.
    Vaccine; 2004 Jun 02; 22(17-18):2199-201. PubMed ID: 15149777
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 02; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 13. [Field trial with a new type of influenza subunit vaccine (author's transl)].
    Kunz C, Hofmann H.
    Wien Klin Wochenschr; 1976 Aug 13; 88(15):504-8. PubMed ID: 997532
    [Abstract] [Full Text] [Related]

  • 14. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U, Pressler K, Erdmann G.
    Zentralbl Bakteriol Orig A; 1975 Jul 13; 232(2-3):160-77. PubMed ID: 1179878
    [Abstract] [Full Text] [Related]

  • 15. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B, Neri M, Lepri E, Iorio AM.
    Vaccine; 2009 Jun 24; 27(31):4099-103. PubMed ID: 19410623
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human responses to purified surface antigen invluenza vaccine (Fluvirin).
    Stones PB, Furminger IG, Kerr J.
    Dev Biol Stand; 2009 Jun 24; 39():239-42. PubMed ID: 604103
    [Abstract] [Full Text] [Related]

  • 20. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.
    J Virol; 2005 Oct 24; 79(19):12401-7. PubMed ID: 16160167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.